It comes in three FDA-approved forms: Ozempic: weekly injection for type 2 diabetes (0.25 to 2.0 mg) Wegovy: weekly injection for obesity (0.25 to 2.4 mg), plus an oral tablet approved December 2025 (50 mg daily) Rybelsus: daily oral tablet for T2D (3, 7, or 14 mg) Off-label use of Ozempic for weight loss is common where insurance covers the diabetes indication but not the obesity one
Read article GLP-1 Weight Loss for the Hispanic Community Hispanic and Latino communities face unique barriers to weight loss care
The supplement is made from organic ingredients, free from gluten, GMOs, and preservatives, making it a safe and natural choice for digestive health
doi: 10.1210/en.2014-1519 85 HuangZHuangLWangCZhuSQiXChenYet al
The GIP receptor (glucose-dependent insulinotropic polypeptide) controls appetite and metabolic function independently from GLP-1, creating a more comprehensive signal to reduce hunger and increase satiety